Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by skiboard09on Jun 11, 2019 11:03pm
93 Views
Post# 29817235

RE:RE:Mgmt’s flying by the seat of their pants

RE:RE:Mgmt’s flying by the seat of their pantsHave you ever seen an Apple investor presentation, the CEO's are wearing Jeans and running shoes. What someone wears has no baring on how the execute. 

Yes today people were disapointed in the NR as it was confusing, but I beleive it is putting us in a better position. In order to even run these higher concentrations you need to get approval from the toxicology side. So getting this approval is a POSITIVE. Not anyone can just get it.

When you are dealing with potential millions of dollars and royalties it takes time. Would you be happy if they just agreed to the first low ball offer. Most likely not. They are trying to extract more value. 

This is all my opinion. I have not sold a single share and I have been in this for over 5 years due to the science and the potential it has in so many markets. 


Bullboard Posts